| Financial Year |
March 31 2023 |
| Monetary Funds |
248,358,585.33 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,323,459.52 |
| Accounts Receivable |
571,241,215.22 |
| Advances to Suppliers |
88,702,610.64 |
| Other Receivables |
10,939,157.49 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,423,800,062.04 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
21,189,527.98 |
| Total Current Assets |
2,395,963,623.13 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
14,687,061.02 |
| Long-term Equity Investment |
-- |
| Investment Properties |
36,768,340.57 |
| Fixed Assetes |
812,768,448.63 |
| Under-construction Projects |
85,515,499.74 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
71,438,771.85 |
| R&D expenses |
-- |
| Goodwill |
120,320,174.46 |
| Long-Term Deferred and Prepaid Expenses |
9,658,185.35 |
| Deferred Income Tax Assets |
20,421,168.68 |
| Other Non-Current Assets |
47,608,517.37 |
| Sub-Total of Non-Current Assets |
1,287,830,887.36 |
| Total Assets |
3,683,794,510.49 |
| Short-Term Loans |
516,174,609.50 |
| Trading Financial liabilities |
-- |
| Notes Payable |
258,806,858.85 |
| Accounts Payable |
463,996,114.76 |
| Accounts Received In Advance |
767,126.70 |
| Employee Compensation Payable |
32,057,299.93 |
| Taxes Payable |
24,175,823.99 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
39,885,317.55 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
115,458,949.80 |
| Other Current Liabilities |
9,602,221.54 |
| Sub-Total of Current Liabilities |
1,579,070,184.94 |
| Long-term Loans |
402,701,237.09 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,081,434.93 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
436,815,969.20 |
| Total Liabilities |
2,015,886,154.14 |
| Paid-In Capital(Or Share Stock) |
226,559,307.00 |
| Capital Surplus |
558,018,354.70 |
| Surplus Reserve |
59,185,335.57 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
811,232,314.59 |
| Minority Stockholder's Interest |
7,848,551.97 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,660,059,804.38 |
| Owner's Equity（Stockholder's Equity） |
1,667,908,356.35 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,683,794,510.49 |
